An allosteric site on MKP5 reveals a strategy for small-molecule inhibition

The MAPK family of kinases regulates diverse physiological and pathophysiological processes and is inactivated by MAPK phosphatases including MKP5. Blocking MKP5 activity has emerged as a potential treatment for dystrophic muscle disease. Gannam et al . identified and characterized a small molecule that inhibited MKP5 by binding to an allosteric site on the phosphatase but that did not affect the…

Read the full article here

Related Articles